These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2871785)

  • 1. Safety profile of bevantolol.
    Bray JS
    Angiology; 1986 Mar; 37(3 Pt 2):248-53. PubMed ID: 2871785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bevantolol vs propranolol: a double-blind controlled trial in essential hypertension.
    Maclean D
    Angiology; 1988 Jun; 39(6):487-96. PubMed ID: 2897812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of bevantolol in the treatment of angina--a placebo-controlled study.
    Farnham DJ
    Angiology; 1986 Mar; 37(3 Pt 2):226-32. PubMed ID: 2871782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose response studies of bevantolol in hypertensive patients.
    Okawa KK
    Angiology; 1986 Mar; 37(3 Pt 2):233-8. PubMed ID: 2871783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of bevantolol and atenolol in chronic stable angina.
    Rodrigues EA; Lawrence JD; Dasgupta P; Hains AD; Lahiri A; Wilkinson PR; Raftery EB
    Am J Cardiol; 1988 Jun; 61(15):1204-9. PubMed ID: 2897780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevantolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris.
    Frishman WH; Goldberg RJ; Benfield P
    Drugs; 1988 Jan; 35(1):1-21. PubMed ID: 2894292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of bevantolol and atenolol for systemic hypertension.
    Fairhurst GJ
    Am J Cardiol; 1986 Nov; 58(12):25E-27E. PubMed ID: 2878597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New specialty drugs registered in Austria. Concor].
    Graffius D
    Wien Klin Wochenschr; 1990 Mar; 102(6):180-4. PubMed ID: 1970446
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence of side effects during the application of placebo and active therapy (Tobanum) in patients suffering from hypertension, angina pectoris and arrhythmia.
    Török E; Kósa E; Szontagh M; Juvancz P; Eggenhofer J; Borvendég J
    Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):650-6. PubMed ID: 2868999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of bevantolol for chronic, stable angina pectoris.
    Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB
    Am J Cardiol; 1986 Nov; 58(12):28E-34E. PubMed ID: 2878598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celiprolol in angina pectoris.
    Soberman JE; Frishman WH
    Am Heart J; 1988 Nov; 116(5 Pt 2):1422-5. PubMed ID: 2903653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of once and twice daily oral dosing schedules of bevantolol, a new beta-adrenoceptor antagonist with alpha-adrenoceptor partial antagonist activity in patients with angina of effort.
    Molajo AO; Bray CL; Hillier V
    Int J Cardiol; 1989 Nov; 25(2):185-92. PubMed ID: 2572566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of bevantolol hydrochloride in patients with severe hypertension. The Cooperative Study Group on Bevantolol in Japan.
    Noshiro T; Miura Y; Yoshinaga K; Iimura O; Inagaki Y; Saruta T; Ishii M; Yamazaki N; Arakawa K
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):240-5. PubMed ID: 7620695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute, short- and long-term efficacy of oral bevantolol in patients with coronary artery disease: a placebo-controlled, randomized, double-blind study.
    Gimeno JV; Ferrer J; Olague J; Bordes P; Serra J; Estruch G; Mainer V; Algarra FJ
    Clin Cardiol; 1986 Sep; 9(9):457-60. PubMed ID: 3530572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of hydrochlorothiazide and hydrochlorothiazide plus bevantolol in hypertension.
    Lucas CP; Morledge JH; Tessman DK
    Clin Ther; 1985; 8(1):49-60. PubMed ID: 2870810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angina pectoris: effective therapy once daily.
    Prager G
    J Int Med Res; 1979; 7(1):39-44. PubMed ID: 33863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind trial of penbutolol: a new beta-receptor blocking agent in the treatment of angina pectoris.
    Agarwal AK; Ahuja RC; Chandra M; Gupta NN; Hasan M
    J Int Med Res; 1976; 4(6):410-7. PubMed ID: 17557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term experience with nadolol in treatment of hypertension and angina pectoris.
    Alexander JC; Christie MH; Vernam KA; Fand RS; Shafer WB
    Am Heart J; 1984 Oct; 108(4 Pt 2):1136-40. PubMed ID: 6148874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tolamolol versus propranolol on systolic time intervals in angina.
    Aronow WS; Vawter M; Spivack N; Warren M; Laverty W
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1069-76. PubMed ID: 4154826
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study of the respiratory effects of two beta 1-selective blocking agents atenolol and bevantolol in asthmatic patients.
    Philip-Joet F; Saadjian A; Bruguerolle B; Arnaud A
    Eur J Clin Pharmacol; 1986; 30(1):13-6. PubMed ID: 2872059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.